| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $2.9B | $3.0B | $2.7B | $2.0B | $0.4B | $0.7B | $0.8B |
| Cost of Revenue | — | — | $1.8B | $1.7B | $1.3B | $1.3B | $1.9B | $2.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.5B | $0.2B | $0.4B | $0.2B | $-0.1B | $-0.2B | $0.1B | $0.1B |
| Net Income | $0.3B | $-0.2B | $-0.0B | $-0.4B | $-0.6B | $-0.1B | $-0.3B | $-0.2B |
| EPS (Basic) | $18.75 | $-22.37 | $-5.49 | $-40.52 | $-76.58 | $-16.45 | $-0.77 | $-0.55 |
| EPS (Diluted) | $17.39 | $-22.37 | $-5.49 | $-40.52 | $-76.58 | $-16.45 | $-0.77 | $-0.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.8B | $4.5B | $5.3B | $4.7B | $5.5B | $5.5B | $6.8B | $7.9B |
| Current Assets | $1.6B | $1.0B | $1.6B | $1.0B | $1.5B | $1.1B | $1.2B | $1.6B |
| Cash & Equivalents | $0.9B | $0.4B | $1.1B | $0.5B | $1.0B | $0.5B | — | — |
| Total Liabilities | $3.4B | $3.3B | $4.0B | $3.5B | $4.1B | $3.8B | $4.3B | $4.7B |
| Current Liabilities | $1.0B | $0.6B | $1.2B | $0.6B | $0.5B | $0.5B | $0.7B | $0.8B |
| Stockholders' Equity | $0.6B | $0.1B | $0.3B | $0.4B | $0.6B | $1.2B | $2.0B | $2.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.6B | $0.6B | $0.5B | $0.4B | $0.3B | $0.7B | $0.3B |
| Investing Cash Flow | $0.1B | $-0.6B | $-0.6B | $-0.4B | $-0.1B | $-0.2B | $-0.4B | $-0.4B |
| Capital Expenditures | $0.7B | $0.6B | $0.5B | $0.4B | $0.2B | — | — | — |
| Financing Cash Flow | $-0.6B | $-0.7B | $0.6B | $-0.7B | $0.5B | $-0.1B | $-0.3B | $0.2B |